Stocks and Investing Stocks and Investing
Tue, July 19, 2022
Mon, July 18, 2022

Rick Wise Maintained (ABT) at Strong Buy with Decreased Target to $126 on, Jul 18th, 2022


Published on 2024-10-27 22:01:27 - WOPRAI, Rick Wise
  Print publication without navigation


Rick Wise of Stifel, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $136 to $126 on, Jul 18th, 2022.

Rick has made no other calls on ABT in the last 4 months.



There are 11 other peers that have a rating on ABT. Out of the 11 peers that are also analyzing ABT, 1 agrees with Rick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 10 analyists that currently disagree with Rick


  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $134 on, Friday, July 15th, 2022
  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $117 on, Friday, July 15th, 2022
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $130 on, Wednesday, July 13th, 2022
  • Mike Polark of "Wolfe Research" Initiated at Sell on, Wednesday, July 6th, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy with Decreased Target to $116 on, Tuesday, July 5th, 2022
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Decreased Target to $130 on, Friday, June 24th, 2022
  • Travis Steed of "B of A Securities" Maintained at Strong Buy and Held Target at $140 on, Tuesday, May 31st, 2022
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Tuesday, May 17th, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
Contributing Sources